Director, Clinical Trials Unit
Discipline Head, Medical Oncology
Faculty of Medicine, Health and Human Sciences Macquarie University
Sidney, Australia
Professor Howard Gurney is the Director of Clinical Trials and Discipline Head for Medical Oncology in the Faculty of Medicine, Health and Human Sciences at Macquarie University and Medical Oncologist at Westmead Hospital in Sydney, Australia.
Dr Gurney has a firm background in clinical research and has subspecialty interests in uro-genital cancers including prostate, bladder, testis and kidney cancer.
He has been the principal investigator for over 120 clinical trials and has over 120 per-reviewed publications in genitourinary cancers and pharmacogenomics, including recent papers in the New Engl J Med, Lancet and Lancet Oncology, with a H-index of 43. His publications have over 12,000 citations and over 8,000 in the last 5 years. Current research interests also include the pharmacogenomics and therapeutic monitoring of chemotherapy and targeted therapies and he has published widely in this area. He is regarded as a leading authority on mechanisms for safe dosing of anticancer agents and has held research grants and has written several invited editorials on these topics.